Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines
about
Genetics and genomics of radiotherapy toxicity: towards predictionGenetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association studyCancer pharmacogenomics: strategies and challengesIn vitro human cell line models to predict clinical response to anticancer drugsTreatment of Radiation InjuryLung Cancer Gene Signatures and Clinical PerspectivesFKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancerGenome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1Follow-up study of abnormal biological indicators and gene expression in the peripheral blood of three accidentally exposed personsThiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes.Genomewide analysis of inherited variation associated with phosphorylation of PI3K/AKT/mTOR signaling proteinsAlternative transcript initiation and splicing as a response to DNA damage.Use of the gamma method for self-contained gene-set analysis of SNP dataGenetic association studies of copy-number variation: should assignment of copy number states precede testing?Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomicsSimultaneous analysis of multiple data types in pharmacogenomic studies using weighted sparse canonical correlation analysisIdentifying the genetic variation of gene expression using gene sets: application of novel gene Set eQTL approach to PharmGKB and KEGG.Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancerRadiation-induced apoptosis varies among individuals and is modified by sex and age.Acetaminophen-NAPQI hepatotoxicity: a cell line model system genome-wide association study.Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)A neutrality test for detecting selection on DNA methylation using single methylation polymorphism frequency spectrum.Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapyGenetic variation is the major determinant of individual differences in leukocyte endothelial adhesion.Chemotherapeutic-induced apoptosis: a phenotype for pharmacogenomics studies.Mycophenolic acid response biomarkers: a cell line model system-based genome-wide screen.Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy.Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.Bora downregulation results in radioresistance by promoting repair of double strand breaks.Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.Genetic variation in radiation-induced cell death.Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translationSerine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterizationMutations of the human interferon alpha-2b (hIFNα-2b) gene in cancer patients receiving radiotherapy.Transcriptomic Signatures of Auger Electron Radioimmunotherapy Using Nuclear Targeting (111)In-Trastuzumab for Potential Combination Therapies.Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expressionEstrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation.Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease RecurrenceTSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.Computational discovery of transcription factors associated with drug response.
P2860
Q21183971-0F9F6F46-E8E3-4F1F-BE00-C072EB93D05DQ21261276-747EE3A4-B78B-47B6-9ECB-FBBE20462D6CQ24289309-8EA1A5D8-802C-4A4E-936F-C20BEDDE58ACQ27000665-6CEC9037-7F49-46DD-9E63-CDAE8D01BFADQ27003920-117BF64E-289A-4F17-910E-523CF2BFB5C1Q28387769-11A16328-C417-4198-8DC6-48E01CAC0B6CQ28483623-CB1DA423-40AC-455E-B431-32F5DDDFD03BQ28943506-596EF7E1-4476-4ABC-9C35-7EF3B13BB6A3Q30544265-F9A92BD3-AEAA-433C-8B0D-CF402D469F8EQ33637143-62D91C9D-11FB-4EDB-9B0E-0499224AAA00Q34031558-ECB207E3-C213-4FA2-8DC1-5F60D457925BQ34062261-C75E6745-0BC4-4936-8958-2A964D57E7F9Q34100207-7710FA28-0683-4F7C-964F-2193B60B4DA8Q34228348-19D91AE7-B635-4BFA-BF00-79CF093C1BEBQ34265045-96AE3EEA-D26A-43B4-991F-5D4925E72D8BQ34317474-580DDF0E-2685-4716-947D-F84C6898294FQ34384986-60D79E89-EBB4-4163-8E30-6AB956C9DB57Q34389016-B2C0DE6F-3BBD-49D9-BC37-5D8526D3CBFEQ34463885-332350E7-5723-4FCD-9AD7-ED48A969C70DQ34601408-5B40A899-B436-4633-9F38-C032D57F4AFEQ34937030-E94CC893-C12E-4034-A363-808F9DA4B817Q35047520-BC0BA5E2-9440-4B48-8C59-BDAADE087C9AQ35084218-72FBD1AD-E762-48DC-96BC-7D2C7F064CD7Q35092664-EF3F389E-10F5-40FE-ABA9-84509888E342Q35099987-173E5968-5F52-4EDD-96AC-A522C92F3519Q35112606-944642A4-515D-48A9-8A4F-2A55D9D2A4E9Q35196480-46B2D3EC-7E76-423B-B15C-6D076F1CCE83Q35565624-69B6365A-E862-412B-949B-EC7D16298510Q35572248-53CB090E-7553-431C-8DF0-AC3CEF35EED8Q35675274-623098E7-A83B-4ED1-8B22-A36E0555640CQ35694405-77CFDE92-DD6D-47D4-960C-4D2BE4FCB5C6Q35799841-CE8DA85E-25DE-469D-9EDC-64A7A141DE7CQ35812635-C647B3A5-8008-4751-A51C-9BFED26925C3Q36057129-CEA4AB06-90AD-405D-A853-9C2609338CA2Q36148279-87BE1416-BC9E-4281-8002-1CF477402E9FQ36245513-08889695-D092-484F-9D79-B843AC5F611FQ36632405-E43847BD-65AD-430B-A4B4-2EC71E87DD5CQ36712351-7C2A14E1-6E4F-44F0-B52B-D739AAE886A5Q36714877-8FD4D27F-442F-4CC9-8A02-0D37214A8C25Q36844885-24E59C5B-230E-42B3-8D89-FC6616A3B883
P2860
Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Radiation pharmacogenomics: a ...... uman lymphoblastoid cell lines
@ast
Radiation pharmacogenomics: a ...... uman lymphoblastoid cell lines
@en
Radiation pharmacogenomics: a ...... uman lymphoblastoid cell lines
@nl
type
label
Radiation pharmacogenomics: a ...... uman lymphoblastoid cell lines
@ast
Radiation pharmacogenomics: a ...... uman lymphoblastoid cell lines
@en
Radiation pharmacogenomics: a ...... uman lymphoblastoid cell lines
@nl
prefLabel
Radiation pharmacogenomics: a ...... uman lymphoblastoid cell lines
@ast
Radiation pharmacogenomics: a ...... uman lymphoblastoid cell lines
@en
Radiation pharmacogenomics: a ...... uman lymphoblastoid cell lines
@nl
P2093
P2860
P921
P356
P1433
P1476
Radiation pharmacogenomics: a ...... uman lymphoblastoid cell lines
@en
P2093
Brooke L Fridley
Gregory D Jenkins
Junmei Hou
Krishna R Kalari
Liewei Wang
Minjia Zhu
Nifang Niu
P2860
P304
P356
10.1101/GR.107672.110
P577
2010-10-05T00:00:00Z